Did you know?

ChinaBio^® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

Free Report

State of China Life Science 2022

Free Content

Week in Review

In My Opinion

Free Articles

Subscriber Content

Germany's Merck Opens Biologics CRO/CMO in Shanghai

publication date: Sep 22, 2017

Germany's Merck has opened a BioReliance biologics CRO/CMO in Shanghai. The BioReliance End-to-End Biodevelopment Center will offer services to the entire Asia Pacific region. Merck acquired BioReliance in 2015 as part of its larger $17 billion Sigma-Aldrich acquisition. A chemical company, Sigma-Aldridge (now known as MilliporeSigma) offers lab equipment and supplies, including biotech services. The BioReliance Center will provide a full range of process development services, including cell line development, upstream and downstream process development and non-GMP clinical production. More details....

Stock Symbol: (F: MRK)

Share this with colleagues:

This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

Click here to join.